Skip to content

Company

Chugai Pharmaceutical

Structure of Chugai Pharmaceutical

Chugai Pharmaceutical

Company

1 connections
OwnershipInvestment and holdings
Relationship began2026
Chugai PharmaceuticalCompany · 1 connections
Layer 1

OwnershipInvestment and holdings1

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

  • Rocheowns →Chugai Pharmaceutical
    Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-07 13:00
      Roche is the majority shareholder in Chugai Pharmaceutical, a major innovator in the Japanese therapeutic antibody market.
      View source
    • CompanyPR Newswire news releases2026-10-07 13:00
      Roche is the majority shareholder in Chugai Pharmaceutical
      View source

Showing 1 to 1 of 1

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 2
ownsRoche

Roche is the majority shareholder in Chugai Pharmaceutical, a major innovator in the Japanese therapeutic antibody market.

PR Newswire news releases · 2026-10-07 13:00

View evidence
  • CompanyPR Newswire news releases2026-10-07 13:00
    Roche is the majority shareholder in Chugai Pharmaceutical, a major innovator in the Japanese therapeutic antibody market.
    View source
  • CompanyPR Newswire news releases2026-10-07 13:00
    Roche is the majority shareholder in Chugai Pharmaceutical
    View source

Showing 1 to 1 of 1

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Not available: Company signals · Financials · Filings · Guidance